Bionomics Limited
NASDAQ:BNOX
0.6587 (USD) • At close September 13, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Revenue
| 0.433 | 4.181 | 0.696 | 2.065 | 5.17 | 8.794 | 20.789 | 14.326 |
| Cost of Revenue
| 13.063 | 11.046 | 4.321 | 4.022 | 8.516 | 18.686 | 18.618 | 18.453 |
| Gross Profit
| -12.631 | -6.865 | -3.625 | -1.957 | -3.345 | -9.892 | 2.171 | -4.127 |
| Gross Profit Ratio
| -29.193 | -1.642 | -5.209 | -0.948 | -0.647 | -1.125 | 0.104 | -0.288 |
| Reseach & Development Expenses
| 13.063 | 11.046 | 4.321 | 4.022 | 8.516 | 18.686 | 18.618 | 18.453 |
| General & Administrative Expenses
| 5.752 | 5.108 | 3.279 | 2.533 | 4.683 | 6.861 | 4.401 | 5.607 |
| Selling & Marketing Expenses
| 0.147 | 0.181 | 0.954 | 0.815 | 0.851 | 1.049 | 1.994 | 2.26 |
| SG&A
| 5.899 | 5.289 | 4.233 | 3.348 | 5.534 | 7.909 | 6.395 | 7.867 |
| Other Expenses
| 0 | 0.007 | 0.203 | 0.2 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 9.024 | 8.278 | 1.972 | 0.984 | 2.475 | 8.437 | 6.368 | 8.281 |
| Operating Income
| -18.529 | -12.15 | -7.706 | -5.167 | -8.879 | -17.801 | -4.224 | -11.994 |
| Operating Income Ratio
| -42.826 | -2.906 | -11.073 | -2.502 | -1.717 | -2.024 | -0.203 | -0.837 |
| Total Other Income Expenses Net
| -2.82 | -3.006 | 1.044 | 1.007 | 1.455 | -1.625 | -0.562 | -0.912 |
| Income Before Tax
| -21.349 | -15.155 | -6.662 | -4.159 | -7.425 | -19.426 | -4.786 | -12.906 |
| Income Before Tax Ratio
| -49.343 | -3.625 | -9.573 | -2.014 | -1.436 | -2.209 | -0.23 | -0.901 |
| Income Tax Expense
| 0.138 | 0.132 | 0.141 | 0.143 | 0.121 | 0.859 | 0.402 | 0.545 |
| Net Income
| -21.212 | -15.023 | -6.521 | -4.016 | -7.303 | -18.567 | -5.188 | -12.361 |
| Net Income Ratio
| -49.025 | -3.593 | -9.371 | -1.945 | -1.413 | -2.111 | -0.25 | -0.863 |
| EPS
| -2.6 | -2.49 | -1.51 | -1.33 | -2.53 | -6.93 | -1.94 | -4.87 |
| EPS Diluted
| -2.6 | -2 | -1.51 | -1.33 | -2.52 | -6.93 | -1.94 | -4.82 |
| EBITDA
| -17.873 | -11.512 | -7.002 | -4.187 | -7.873 | -16.567 | -2.885 | -10.551 |
| EBITDA Ratio
| -41.308 | -2.754 | -10.062 | -2.027 | -1.523 | -1.884 | -0.139 | -0.736 |